Sökresultat

A new and promising approach for treatment of lung cancer has been developed by researchers at Lund University. The treatment combines a novel surgical approach with smart nanoparticles to specifically target lung tumors. The new study has been published in the July issue of Advanced Therapeutics. Lung tumors are often difficult to remove using current surgical techniques due to their location in

https://www.lucc.lu.se/article/new-promising-treatment-uses-smart-nanoparticles-target-lung-cancer - 2026-01-07

A new study from Lund University and Region Skåne in Sweden indicates that potency-enhancing PDE5 inhibitor drugs have an anti-cancer potential with the ability to improve the prognosis in patients with colorectal cancer. PDE5 inhibitors include a few approved drugs in which sildenafil (Viagra) is the most well-known. The article is published in Nature Communications. “Available preclinical eviden

https://www.lucc.lu.se/article/potency-enhancing-drugs-linked-decreased-risks-men-colorectal-cancer - 2026-01-07

Emma Hammarlund was one of six researchers from Lund University in Sweden that was granted five-year starting grants from the European Research Council. Emma Hammarlund, geobiologist and researcher at the Division of Translational Cancer Research, will investigate how life could develop on our planet. The availability of oxygen has long been the prime focus for different hypotheses, however resear

https://www.lucc.lu.se/article/lucc-researcher-receive-erc-starting-grant - 2026-01-07

Researchers at Lund University in Sweden have developed a computational model which is effective in detecting and identifying genetic mutations in breast tumours. The study, the largest of its kind in the world, includes results from over 3 200 patients with breast cancer. The researchers used RNA sequencing, a sensitive, precise tool which has very gradually started to be applied clinically, alth

https://www.lucc.lu.se/article/new-analytical-model-detects-mutations-breast-cancer - 2026-01-07

A drug has shown great promise in the treatment of neuroblastoma, an aggressive form of childhood cancer. The study was led by researchers at Lund University in Sweden, and is published in the journal Science Translational Medicine. Every year, about 800 children in the US are diagnosed with neuroblastoma, an aggressive cancer of the nervous system that most frequently arises in the adrenal glands

https://www.lucc.lu.se/article/promising-treatment-aggressive-childhood-cancer - 2026-01-07

Approximately 10–15 per cent of breast cancer cases do not respond to treatment with hormone therapy, which means that they are more aggressive and often recur. An international research team led by researchers at Lund University in Sweden has uncovered a way to treat these aggressive tumours through manipulation of the connective tissue cells of the tumour. The researchers are now developing a ne

https://www.tcr.lu.se/article/new-treatment-aggressive-breast-cancer - 2026-01-07

Six LU researchers receive ERC Starting Grants Colourful common wall lizards, an innovative X-ray microscope and advanced research on Alzheimer’s, leukaemia, photographic evidence and the origin of life. Six researchers from Lund University in Sweden have been granted five-year starting grants totalling EUR 9.5 million from the ERC.  Follow this link for full article.Follow this link for Emma Hamm

https://www.tcr.lu.se/article/pi-emma-hammarlund-receives-erc-grant - 2026-01-07

A drug has shown great promise in the treatment of neuroblastoma, an aggressive form of childhood cancer. The study was led by researchers at Lund University in Sweden, and is published in the journal Science Translational Medicine. Every year, about 800 children in the US are diagnosed with neuroblastoma, an aggressive cancer of the nervous system that most frequently arises in the adrenal glands

https://www.tcr.lu.se/article/promising-treatment-aggressive-childhood-cancer - 2026-01-07

Emma Hammarlund and Sofie Mohlin at TCR, together with two colleagues from Oxford University, have reviewed how oxygen-sensing mechanisms across eukaryotic kingdoms are alike. From a functional perspective, these systems are active at low oxygen and degraded at high, although their scope varies.    2020-11-16_hammarlund_et_al_2020.pdf .

https://www.tcr.lu.se/article/oxygen-sensing-mechanisms-across-eukaryotic-kingdoms-and-their-roles-complex-multicellularity - 2026-01-07

 Big congratulations to PI:s Daniel Bexell Novel treatment for high-risk neuroblastoma, Christer Larsson Mechanisms determining breast cancer cell fate upon death receptor stimulation - apoptosis or a change in phenotype, Ramin Massoumi Targeted therapy against metastatic melanoma and Sofie Mohlin An Embryonic Model in the Search for Childhood Cancer Initiation on receiving grants from Cancerfonde

https://www.tcr.lu.se/article/pis-tcr-receive-cancerfonden-grants - 2026-01-07

SAVE THE DATE for this upcoming event. Dear all, We hope you are all keeping yourselves safe and healthy through this challenging time.We would like to cordially invite you to a digital imaging meeting including short presentations and discussions about existing imaging facilities and the need for development of the imaging infrastructure at Lund University.When and where: 14th of April 2021, betw

https://www.tcr.lu.se/article/coming-lucc-imaging-nuclear-medicineradiology-seminar - 2026-01-07

Big congratulations to PI:s Håkan Axelson Transformation of renal epithelial cells: the nephron and renal cell carcinoma, Anders Bjartell Integration of Biomarkers in Clinical Models for Improved Outcome Prediction and New Therapies in Prostate Cancer, Emma Hammarlund Utilizing the isotopic elemental fingerprint of cancer to understand tumorgenesis and for the development of truly non-invasive dia

https://www.tcr.lu.se/article/pis-tcr-receive-cancerfonden-grants-0 - 2026-01-07

Big congratulations to Alexander Pietras group on receiving ERC grant. Tumor recurrence and therapeutic resistance: exploring and exploiting the post-radiotherapy brain microenvironment for therapeutic opportunities in malignant brain tumors.  

https://www.tcr.lu.se/article/alexander-pietras-group-receives-erc-grant - 2026-01-07

Big congratulations to: Alexander Pietras, The irradiated brain tumor microenvironment: Biology and therapeutic tagets, on receiving Senior Investigator Award, and to Paulina Bolivar, in Kristian Pietras group, Integrative single-cell and spatial analyses to reveal micriniche organization in the tumor microenvironment of triple negative breast cancer, on receiving Postdoc grant from Cancerfonden.

https://www.tcr.lu.se/article/new-cancerfonden-grants - 2026-01-07

PI Daniel Bexell has been awarded millions in funding from Åke Wibergs foundation that goes to young PIs in medical research. One of the aims is to find out why some tumors develop resistance to today’s treatment but also to find new treatment strategies. Every year around 20 children in Sweden are diagnosed with Neuroblastoma, most before even turning 5 years of age. It is a rare and complexed tu

https://www.tcr.lu.se/article/millions-funding-pi-daniel-bexell - 2026-01-07

The platelet-derived growth factor (PDGF) signalling pathway is often dysregulated in cancer and PDGF-receptor expression has been linked to unfavourable prognostic factors in breast cancer (e.g. ER negativity, high Ki67 and high grade). This study aimed to evaluate the expression of PDGFRα, PDGFRβ and ligand PDGF-CC in breast cancer in relation to molecular subtypes and prognosis. Methods: Protei

https://www.tcr.lu.se/article/pdgf-pathway-breast-cancer-linked-tumour-aggressiveness-triple-negative-subtype-and-early-recurrence - 2026-01-07

Congratulations to Yvonne Ceders group and to Alexander Pietras group on receiving Cancerfonden grants.

https://www.tcr.lu.se/article/researchers-tcr-receives-cancerfonden-grants - 2026-01-07

Big congratulations to Göran B Jönssons group (Oncology), Kristian Pietras group and Joan Yuans group (Developmental Immunology) on receiving a joint grant from Knut and Alice Wallenbergs Foundation (KAW).   Article about the project via this link (in Swedish).

https://www.tcr.lu.se/article/researcher-tcr-receives-kaw-grant - 2026-01-07

Big congratulations to  Kazi Uddins group on receiving Barncancerfonden grant for "Utveckling av riktade kombinationsterapi och nya verktyg för att förutspå terapi-resistens" and to Alexander Pietras group on receiving Barncancerfonden grant for "Syrebristberoende måltavlor i barngliom och ponsgliom".

https://www.tcr.lu.se/article/researchers-tcr-receive-barncancerfonden-grants - 2026-01-07

Big congratulations on receiving grants from Swedish Research Council (Vetenskapsrådet, VR):Daniel Bexell, Mekanismer och nya behandlingsstrategier mot resistent neuroblastom, and to...Anders Bjartell, Målriktade behandlingar och biomarkörer vid avancerad prostatacancer, and to...Kristian Pietras, Definiering av funktionella cell-nischer i tumörens mikromiljö som mål för precisionsmedicin.

https://www.tcr.lu.se/article/researchers-tcr-receive-swedish-research-council-grants - 2026-01-07